Antibiotic Treatment and Antibiotic Resistance of Enterococcus Infections, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 1430
Special Issue Editors
Interests: hygiene; prophylaxis; healthcare-associated infections; microbiology; clinical pathology; antibiotic resistance
Special Issues, Collections and Topics in MDPI journals
Interests: microbiology and virology; antimicrobial stewardship; medicine; epigenetic; drug discovery; alert germs
Special Issues, Collections and Topics in MDPI journals
Interests: antibiotics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first volume of the Special Issue “Antibiotic Treatment and Antibiotic Resistance of Enterococcus Infections” was published in 2022. Following its success, we are pleased to announce the launch of a second volume, focusing on the same topic.
As a continuation of the Special Issue published in 2022, this second volume will also deliver an invaluable compendium of the latest treatments for Enterococcus infections and the latest research on antibiotic resistance in Enterococcus. Topics of interest may include, but are not limited to, the following:
- Epidemiological studies of enterococcal infection and trends in antibiotic resistance;
- Discoveries and genetic studies of new drug resistance genes in Enterococci;
- Surveillance of enterococcal resistance in healthcare settings;
- Antibiotic treatment of Enterococcus infections.
Dr. Giovanni Boccia
Dr. Gianluigi Franci
Dr. Biagio Santella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics
- antimicrobial resistance
- enterococcus faecium
- enterococcus faecalis
- drug resistance
- epidemiologic studies
- endocarditis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
